The White House budget office is reviewing an FDA proposed rule that clarifies what kind of evidence the agency will consider when determining a product’s intended use. FDA attempted to amend the definition three years ago by tucking the changes into a larger tobacco rule, but it then nixed the move after receiving pushback from Republican lawmakers and industry stakeholders. FDA sent its notice of proposed rulemaking, “Amendments to ‘Intended Use’ Regulations,” to the White House Office of Management and...